James B. Renacci bought Ingevity Corp (NYSE: NGVT)
James B. Renacci (R-OH), a U.S. Representative, has disclosed 1 trade in Ingevity Corp (NGVT) since 2017, a single purchase, worth an estimated $33K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a purchase: James B. Renacci bought $15,001 - $50,000 of Ingevity Corp (NYSE: NGVT) on June 20, 2017. Since that trade, NGVT is up +24.73% against the S&P 500 up +244.50%, an outperformance of -219.77%.
Data updated
James B. Renacci's NGVT trades vs the price
NGVT is up +24.73% since James B. Renacci bought on June 20, 2017, versus +244.50% for the S&P 500.
Performance since this trade
All James B. Renacci NGVT trades
James B. Renacci & NGVT trading FAQ
Is it legal for James B. Renacci to trade Ingevity Corp (NGVT) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Ingevity Corp (NGVT), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did James B. Renacci buy NGVT?
James B. Renacci disclosed a purchase of $15,001 - $50,000 of Ingevity Corp (NGVT) on June 20, 2017, according to public STOCK Act filings.
How has NGVT performed since James B. Renacci's trade?
Since James B. Renacci bought NGVT on June 20, 2017, the stock is up +24.73%, versus +244.50% for the S&P 500 over the same period, an outperformance of -219.77%.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional NGVT trades?
Quantellect tracks every disclosed congressional trade in Ingevity Corp (NGVT) on the Ingevity Corp congressional trading page, which aggregates filings across all members of Congress.
James B. Renacci's NGVT tradesAll congressional filings for Ingevity CorpJames B. Renacci's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.